exacerbation

Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia – The BESTCILIA randomized placebo-controlled trial
Helene Kobbernagel, Frederik F. Buchvald, Eric G. Haarman, Carmen Casaulta, Samuel A. Collins, Claire Hogg, Claudia E. Kuehni, Jane S. Lucas, Heymut Omran, Alexandra L. Quittner, Claudius Werner, Susanne Rosthøj, Anne L. Sørensen, Kim G. Nielsen

European Respiratory Journal Sep 2019, 54 (suppl 63) RCT5102; DOI: 10.1183/13993003.congress-2019.RCT5102
Low Dose Azithromycin Prophylaxis in Primary Antibody Deficiencies
Cinzia Milito, Federica Pulvirenti, Stefano Tabolli, Maria Carrabba, Giovanna Fabio, Rosamaria Delle Piane, Maria Cristina Pietrogrande, Francesco Cinetto, Carlo Agostini, Alessandro Plebani, Vassilios Lougaris, Anna Rosa Soresina, Andrea Matucci, Alessandra Vultaggio, Giuseppe Spadaro, Antonio Pecoraro, Baldassarre Martire, Isabella Quinti

European Respiratory Journal Sep 2019, 54 (suppl 63) RCT5100; DOI: 10.1183/13993003.congress-2019.RCT5100
Oral antibiotics vs placebo for exacerbations of paediatric bronchiectasis
Vikas Goyal, Keith Grimwood, Rob Ware, Catherine Brynes, Peter Morris, Ian Masters, Gabrielle Mccallum, Michael Binks, Heidi Smith-Vaughan, Kerry-Ann O’Grady, Anita Champion, Helen Buntain, André Schultz, Mark Chatfield, Paul Torzillo, Anne Chang

European Respiratory Journal Sep 2019, 54 (suppl 63) RCT5101; DOI: 10.1183/13993003.congress-2019.RCT5101
Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort
Marion Fahey, Wilhelmine Meeraus, Celine El Baou, Hana Mullerova, Edith M. Hessel, William A. Fahy

European Respiratory Journal Sep 2019, 54 (suppl 63) PA5223; DOI: 10.1183/13993003.congress-2019.PA5223
Asthma exacerbation patterns in middle-aged and older adults; the Rotterdam Study
Emmely W. de Roos, Lies Lahousse, Arfan Ikram, Bruno Stricker, Guy Brusselle

European Respiratory Journal Sep 2019, 54 (suppl 63) PA5070; DOI: 10.1183/13993003.congress-2019.PA5070
Factors associated with increased arterial stiffness in patients with chronic hypersensitivity pneumonitis
Elena Leonova, Evgeny Shmelev

European Respiratory Journal Sep 2019, 54 (suppl 63) PA5187; DOI: 10.1183/13993003.congress-2019.PA5187
Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial
Benjamin Hartley, Sally Lettis, David Lipson, Paul Jones, Courtney Crim, Mark Dransfield, David Singh, Neil Martin, Neil Barnes

European Respiratory Journal Sep 2019, 54 (suppl 63) PA5230; DOI: 10.1183/13993003.congress-2019.PA5230
Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations
Sergi Pascual, Pau Puigdevall, Carme Casadevall, Esther Barreiro, Robert Castelo, Joaquim Gea Guiral

European Respiratory Journal Sep 2019, 54 (suppl 63) PA5233; DOI: 10.1183/13993003.congress-2019.PA5233
ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study
Leila Karimi, Lies Lahousse, Mohsen Ghanbari, Natalie Terzikhan, André G. Uitterlinden, Johan Van Der Lei, Guy G. Brusselle, Bruno H. Stricker, Katia M. C. Verhamme

European Respiratory Journal Sep 2019, 54 (suppl 63) PA5389; DOI: 10.1183/13993003.congress-2019.PA5389
ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium
Leila Karimi, Susanne J. Vijverberg, Marjolein Engelkes, Natalia Hernandez-Pacheco, Niloufar Farzan, Patricia Soares, Ben R. Francis, Maria Pino-Yanes, Celeste Eng, Somnath Mukhopadhyay, Maximilian Schieck, Michael Kabesch, Esteban G Burchard, Colin N.A Palmer, Steve Turner, Hettie M Janssens, Anke-Hilse Maitland-Van Der Zee, Katia M Verhamme

European Respiratory Journal Sep 2019, 54 (suppl 63) PA5388; DOI: 10.1183/13993003.congress-2019.PA5388

Main menu

User menu

Search

exacerbation

Pages

Contact us